CSL posts $US2.4b profit but warns of weaker years ahead
MELBOURNE: CSL chief executive Paul Perreault says the biotech giant is preparing for future investment
MELBOURNE: CSL chief executive Paul Perreault says the biotech giant is preparing for future investment
FEATURED
Once-a-day Alzheimer’s pill reaches US approval milestone
Builder to start innovative retirement living project in city
Work gets under way on cooperative housing for the elderly
Developers pitch luxurious retirement homes to win reluctant downsizers
French lessons in art of urban regeneration show ‘People come first’
Couple takes on new adventure as caretakers of the island
INNOVATION
